E-LIB Suche - Ergebnisse für: Jacques, Francois

1

Satisfaction with alemtuzumab in relapsing multiple scleros..:

Wray, Sibyl ; Jacques, Francois ; Miller, Tamara A...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8 (2022) 4 - p. 205521732211358 , 2022

Link: https://doi.org/10.1177/..

2

Avelumab in Newly Diagnosed Glioblastoma Multiforme-the SEJ..:

Jacques, Francois ; Lorimer, Ian ; Nicholas, Garth...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

3

Single Digit Modality: What is a Clinically Significant Cha..:

Jacques, Francois ; Schembri, Adrian ; Paquette, Chantal
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

4

Multicentre assessment of motor and sensory evoked potentia..:

Hardmeier, Martin ; Jacques, François ; Albrecht, Philipp...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5 (2019) 2 - p. 205521731984479 , 2019

Link: https://doi.org/10.1177/..

5

ATIM-12. AVELUMAB IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORM..:

Jacques, Francois ; Nicholas, Garth ; Lorimer, Ian..
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi4-vi4 , 2019

Link: https://doi.org/10.1093/..

6

Treatment Sequencing and Satisfaction With Alemtuzumab in R..:

Wray, Sibyl ; Jacques, Francois ; Miller, Tamara A....
Neurology. 92 (2019) 15_supplement - p. , 2019

Link: https://doi.org/10.1212/..

7

T85. Sensory and motor evoked potentials in a multicenter s..:

Hardmeier, Martin ; Jacques, François ; Albrecht, Philipp...
Clinical Neurophysiology. 129 (2018) - p. e34-e35 , 2018

Link: https://doi.org/10.1016/..

8

Prolonged-Release Fampridine as Adjunct Therapy to Active M..:

Jacques, François ; Schembri, Adrian ; Nativ, Avi..
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 4 (2018) 1 - p. 205521731876116 , 2018

Link: https://doi.org/10.1177/..

9